News | November 10, 2025
Marksans Pharma's Goa unit clears FDA inspection
The said inspection concluded with Zero Form 483 observation
The said inspection concluded with Zero Form 483 observation
Venus Remedies now has 29 active product approvals in Vietnam alone
The FDA setback highlights ongoing tensions between patient needs, regulatory processes, and the use of real-world evidence in evaluating treatments for rare diseases
Poviztra is a second brand of Wegovy
Poly Medicure has reported total income of Rs. 477.82 crore during the period ended September 30, 2025
Sales from Novo’s GLP-1 portfolio—including Wegovy for obesity and Ozempic for type 2 diabetes reached $5.6 billion
This latest commitment brings the British pharmaceutical company’s total investment at the site to $886 million
The device delivers clear, high-quality images to support accurate diagnoses across a broad range of patient groups
Adjusted EBITDA increased by 12.3 per cent to $531 million, up from $516 million in the same period last year
Comirnaty, Pfizer’s COVID-19 prevention vaccine, reported global sales of $1.15 billion
Subscribe To Our Newsletter & Stay Updated
